us xenoport fda review 110909
On the homepage
Sunday's paper
Out There
Reusse/Souhan
Schools
XenoPort and Glaxo says FDA review of neuropathic pain drug extended 3 months, to Feb. 2010
Print this story
E-mail this story
Save to del.icio.us
Share on Facebook
Share on Digg
Minnesota business by the numbers
See Minnesota's top earning companies, CEOs and non-profits
More from Business
NEW YORK - The Food and Drug Administration needs three more months to review an application to a neuropathic pain drug being developed by XenoPort Inc. and GlaxoSmithKline PLC, the companies said.
XenoPort and GlaxoSmithKline said late Friday the FDA should complete its review of the drug, called gabapentin enacarbil, by Feb. 9, 2010. The review period was scheduled to end Monday. The FDA wanted the companies to develop a strategy to evaluate the drug's risks, and after GlaxoSmithKline submitted that strategy, the agency needed additional time to review it.
XenoPort is based in Santa Clara, Calif., and GlaxoSmithKline is headquartered in London. In premarket trading, XenoPort stock rose 7 cents to $18.21 from $18.14.
Recent Business stories
USDA concern growing as reports shows states struggle to administer food stamps - November 9, 2009
USDA concern growing as reports shows states struggle to administer food stamps - With more Americans going hungry than ever before, the Agriculture Department is concerned that dozens of states aren't adequately administering food stamp programs designed to provide food to low-income Americans. More
- 2 charged with running $190M Ponzi scheme
- Toyota to replace 4M gas pedals that could jam
- Minnesota's banks are bruised, but healing
- FDA says Cheerios health claims lack evidence
- No verdict; Petters jury to resume deliberations Monday
- China executes 2 for role in tainted milk scandal
- 'Good Morning America' cancels Lambert
Blog: Patent Pending
Lights out at U energy conference. Irony police notified.
Just as Lawrence Kazmerski, a top official at the National Renewable Energy Laboratory, was about to give the keynote address at the University of Minnesota's annual E3 conference at the RiverCentre in St. Paul, the lights went out, bathing the audience in darkness and a deep sense of irony.
Comment on this story | Be the first to comment | Hide reader comments